atropine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 3 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (4-iodo-2,5-dimethoxyphenylisopropylamine) | Trials (4-iodo-2,5-dimethoxyphenylisopropylamine) | Recent Studies (post-2010) (4-iodo-2,5-dimethoxyphenylisopropylamine) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 843 | 1 | 127 |
Protein | Taxonomy | atropine (IC50) | 4-iodo-2,5-dimethoxyphenylisopropylamine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0032 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henley, WN; Vladic, F | 1 |
Evenden, J | 1 |
Bourin, M; Hascoët, M; Nic Dhonnchadha, BA; Ripoll, N; Sébille, V | 1 |
3 other study(ies) available for atropine and 4-iodo-2,5-dimethoxyphenylisopropylamine
Article | Year |
---|---|
Hypothyroid-induced changes in autonomic control have a central serotonergic component.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Atropine; Autonomic Nervous System; Blood Pressure; Body Temperature; Brain; Cardiovascular System; Heart Rate; Hypothyroidism; Injections, Intraventricular; Male; Rats; Rats, Sprague-Dawley; Reference Values; Serotonin; Serotonin Receptor Agonists | 1997 |
The effects of psychotomimetics and psychomotor stimulants on two schedules promoting response switching in the rat.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Atropine; Behavior, Animal; Caffeine; Central Nervous System Depressants; Central Nervous System Stimulants; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Food; Hallucinogens; Lysergic Acid Diethylamide; Muscarinic Antagonists; Phencyclidine; Photic Stimulation; Rats; Rats, Long-Evans; Reinforcement Schedule; Scopolamine | 2002 |
The four-plates test-retest paradigm to discriminate anxiolytic effects.
Topics: Adrenergic Uptake Inhibitors; Amphetamines; Animals; Anti-Anxiety Agents; Anxiety; Atropine; Avoidance Learning; Behavior, Animal; Benzodiazepines; Cholinergic Agents; Cyclohexanols; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Mice; Paroxetine; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Venlafaxine Hydrochloride | 2005 |